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Radiographic imaging of Contrast-cnhaneed coronary anert
ies is a cornerstone of current cardinlogic practice . This year
approximately 1 .4 million diagnostic and interventiunal pro-
cedures involving coronary arteriography will be performed
in the United States and this number will probably continue
to grow despite remarkable advances made in alternative
diagnostic techniques . Until recently . the type of contrast
material used for these procedures had earned little anen-
tion. Considerable debate (1,2) has been engendered . how-
ever, by the introduction of several new contrast agents with
less osmolality than that of the traditional high osmolal
media but costing 15 times more .
Similar to the controversy surrounding the choice of
thrombolytic agent for treatment of acute myocardial infarc-
tion, that involving the cost/benefit ratio of low osmolal
contrast media is muddled both by marketing claims of
pharmaceutical companies that derive a major source of
revenue from the more expensive agents and by the almost
religious advocacy of various camps of angiographers . In the
absence of properly designed clinical trials, decisions regard-
ing the choice of contrast agent must be based on small or
nonrandomized investigations like that of Gaspereiti et at . .
reported in this issue of the Journal (3) . To place such
information in perspective, the following questions should
be considered.
How do enntrast media differ? The high osmolal media
are triiodinaled benzoate derivatives that dissociate in solu-
tion into an anion and a cation yielding 3 iodine atoms2
osmotically active particles . The most commonly utilized of
these ratio 3/2 agents ar mixtures of sodium and methylglu •
camine salts of diatrizoie acid formulated to an iodine
concentration of 370 mg/ml . Most high osmolal media have
similar characteristics including an osmolality of about
2,000 mOsndkg. Some, such as Renugrahn. however . have
additional calcium-binding additives that cause more pro-
found hemodynamic 14) and electrophysiologic (51 changes.
These differences become important when the latter agents
are used as comparators in clinical trials .
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A variety of adverse effects associated with high osmolal
media have been attributed at least in pan to their high
usmulality . Contrast media of lessened tonicity have been
obtained by either the production of a nonionic compound
containing 3 iodine atoms/osmotically
active
particle (to-
hexol, iopamidol or ioversol, for example) or the formation
of an ionic dimer having 6 iodine atoms/2 osmotically active
particles (ioxaglate, for example) . In either case a ratio 3
agent is produced having about one hair the ustruiarty of
high osmolal media. Although there appear to be only minor
differences among the nonionic agents, ioxaglate shares
features of both the high osmolal media and the nonionic
media and may he considered a clinically distinct entity .
Are low osmolal media safer? Coronary angiography with
high osmolal media is associated with several side effects
including allergic reactions, nausea and vomiting . renal
impairment . arrhythmia, hypotension and elevated vCntdC-
ul'ir filing pressures . Although these are usually of only
modest clinical signilicance, one half of all serious untoward
events resulting from coronary angiography with high osmo-
lal media may be related to the contrast medium used (6) . In
randomized controlled trials
of high and low osmolal media
for coronary angiography, the latter have resulted in less
hemodynamic and electrophysiologic perturbation (7-11)
and about half the overall incidence of adverse reactions
(12) . The rarity of transient bradycardia and hypotension
accompanying coronary injection with low osmolal media is
a persuasive reminder of the differences between the two
classes of media and has been a convincing stimulus for
conversion to the nonionic medium, Although there have
been few studies comparing low osmolal media agents, there
is a suggestion that nonionic media may be better tolerated
than the ionic diner (13).
A major advantage of low osmolal media is a lessened
incidencc of "allergic" reactions . Although the nature of
these events is not entirely clear, few are mediated by a true
antigen-amlbody reaction (14) . Three large (but nonrandom-
ized) studies I15-17) have demonstrated a lessened incidence
of adverse reactions accompanying intravenous administra-
tion of nonionic media compared with high osmolal media . It
has been suggested that the type of contrast agent adminis-
tered is more predictive of untoward effect than is risk
stratification : a low risk patient given a high osmolal agent is
more likely u' have an adverse event than is a high risk
patient receiving a nonionic agent (16).
Does nonionk contrast cause clots? Thromboembalism is
the bane of angiography . It is a risk inherent with the
introduction of catheters and guide wires into the vascular
system and increased by interventional procedures that
require prolonged catheter manipulation and disrupt the
endothelium . lhromboembolic events have been noted with
all contrast agents ; however, the report (18) of the occur-
rence of thrombus during routine coronary angiography with
nonionic media caused concern that these agents might be
procoagulant . In vitro investigation has revealed that all
0735-1097/91/53 .50
452
	
1,1 INKER
EDITORIAL COMMENT
iodinated contrast media have some anticoagulant 419) and
antiplatelet (20) properties, even though they may differ
quantitatively (21) and perhaps qualitatively 122)
. Further
confounding the issue has been the observation of contrast-
mediated enduthelial damage (231 that could induce throm-
bosis in vivo, Not surprisingly, the ionic agents, which
produce the most physiologic perturbation, have the most
potent anticoagulant and cytotoxic effects . Despite the cur-
rent hematologic debate (24-26) . no in vitro study has
demonstrated an acceleration of thrombus formation with
use of a nonionic contrast medium compared with a saline
control, and it has been suggested that differences in the
intrinsic anticoagulant properties of contrast medium are
unimportant in the presence of systemic anticoagulation
(27) .
The present study. Clinical espenence also fails to sup-
port a procoagulant effect of the nonionic media (28) . A
recent report (29) involving >8,000 patients undergoing
coronary angiography with nonionic contrast medium found
no difference in
the incidence of thromhaemlwfic events in
such patients compared with patients receiving high osmolal
media . However, results in the setting of diagnostic angiog-
rapby may not be extrapolated to interventional procedures .
Although it is difficult to believe that there is a more patent
stimulus to thrombosis than disruption of the arterial wall,
the findings reported by Gasperetti el al . (3) suggest that the
use of nonionic contrast medium in coronary angioplasty is
associated with an increased risk of thrombus formation,
The strength of their study is its clinical relevancy : the
anticoagulant regimen employed was standard, plastic angie-
graphic syringes were utilized and the procedural aspects of
angioplasty apparently were routine .
However, limitations of the investigation (1) should be
examined before its conclusions are accepted
. The study
was retrospective
. nonrandomized and involved a relatively
small number of patients . Because the nonionic agent was
used with the perception that it caused less hcmodynamic
and eleclrophysiologic disturbance . it is diflicull In assume a
truly random assignment of contrast agent
. For example.
prior heparin therapy was needed in 45% of the nonionic and
33% of the ionic media procedures . The investigators tended
to give less procedural Iteparia in these cases and the
adequacy of anticoagulation deriag angioplasty was appar-
ently never assessed-
Coronary thrombus, the authors' primary end point, may
be difficult to distinguish from filling defects caused by
postangioplasty wall disruption . Despite the increased inci-
dence of thrombus, there was no significant difference in
acute complications or in recurrent ischemic events during
follow-up
. Although the risk of procedural thrombus forma-
tion was increased in patients whose condition was unstable,
particularly those receiving a nonionic agent, there appealed
to be no clinical risk related to thrombus present before
angioplasty in contrast to the finding of others (30) .
Finally, those of us who routinely use nonionic contrast
agents for interventional procedures have not been im-
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pressed with an increased incidence of thromboembolic
complications . This view is supported by Lembo et al . (31)
who found in a randomized controlled comparison of high
osmolal media and nonionic contrast medium only a de-
creased incidence of ventricular arrhythmia- associated with
the nonionic agent.
fmplkaffotn. The traditional concept of an ideal angio-
graphic contrast agent is that it has only one property, X-ray
attenuation . Any action that affects homeostasis has usually
been considered undesirable . Currently 80% of inccrvco-
Hunan coronary procedures are performed with low osmolal
media, the majority of which employ nonionic agents . An-
giographers using the latter have been impre,sed by lessened
physiologic perturbation and believe that this is synonymous
with an increased margin of safety- The findings of Gasper .
elti et al . (3),
if confirmed, will have adrammic effect on this
clinical practice . Although it is premature to assign advan-
tage to contrast material having more patent intrinsic anti-
coagulant activity, a warning flag has been raised . Perhaps
this chink in the nonionic armor wdl renew calls for a
properly designed evaluation of the cost/benefit ratio of hi,th
osmolal media compared with both nonionic and ionic lo .v
osmolal media . Only then can the angioglapher feel confi-
dent that he has fulfilled his clinical and fiscal responsibilities
(32) in the choice of radiographic contrast material .
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